trans-2-methyl-2-pentadecenoic acid | 418772-16-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: trans-2-methyl-2-pentadecenoic acid
• 英文别名: (2E)-2-Methyl-2-pentadecenoic acid；(E)-2-methylpentadec-2-enoic acid
• CAS: 418772-16-4
• 化学式: C₁₆H₃₀O₂
• 分子量: 254.413
• InChiKey: XDAVBNHKLPHGGU-CCEZHUSRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  18
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  trans-2-methyl-2-pentadecenoic acid 在 4-二甲氨基吡啶 、 甲酸 、 N,N'-二环己基碳二亚胺 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 2.0h， 生成 (E)-2-Methyl-pentadec-2-enoic acid (1S,2S,3R)-4-hydroxy-2,3-bis-(4-methoxy-benzyloxy)-1-(4-methoxy-benzyloxymethyl)-butyl ester
  参考文献：
  名称：

  卡夫芬净的全合成及结构解析

  摘要：

  已经实现了从发酵培养物 MF6020 中分离出的新型抗真菌剂 khafrefungin 的全合成和结构解析。与其他抑制真菌和哺乳动物中相应酶的抑制剂不同，卡夫芬净不会损害哺乳动物的鞘脂合成。结构解析的基本策略是制备结构简化的 khafrefungin 模拟物 1 和 2 的所有立体异构体，它们分别设计用于阐明 C10、11、12 和 C2'、3'、4' 相对立体化学。将它们的光谱与天然 khafrefungin 的光谱进行比较将鉴定出八种可能的立体异构体，这八种立体异构体的分析细节导致了完整的立体化学归属。

  DOI：

  10.1021/ja0057272

文献信息

• THERAPEUTIC COMPOUNDS AND USES THEREOF
  申请人：Kala Pharmaceuticals, Inc.

  公开号：US20140235634A1

  公开（公告）日：2014-08-21

  Described herein are compounds of Formula (I) or Formula (VI), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I) or Formula (VI) and pharmaceutical compositions thereof that are mucus penetrating. Methods of using the compounds or pharmaceutical compositions thereof for treating diseases are also provided.

  本文描述了公式（I）或公式（VI）的化合物，其药学上可接受的盐以及其药物组合物。还提供了包含公式（I）或公式（VI）化合物及其药物组合物的微粒（例如，纳米颗粒），这些微粒具有穿透黏液的特性。还提供了使用这些化合物或药物组合物治疗疾病的方法。
• NANOSCALE PLATINUM COMPOUNDS AND METHODS OF USE THEREOF
  申请人：Sengupta Shiladitya

  公开号：US20120189571A1

  公开（公告）日：2012-07-26

  The invention is directed to biocompatible conjugated polymer nanoparticles including a copolymer backbone, a plurality of sidechains covalently linked to said backbone, and a plurality of platinum compounds dissociably linked to said backbone. The invention is also directed to dicarbonyl-lipid compounds wherein a platinum compound is dissociably linked to the dicarbonyl compound. The invention is also directed to methods of treating cancer or metastasis. The methods includes selecting a subject in need of treatment for cancer or metastasis and administering to the subject an effective amount of any of the nanoparticles, compounds, or compositions of the invention.

  这项发明涉及生物相容性共轭聚合物纳米颗粒，包括一个共聚物骨架，多个共价连接到该骨架的侧链，以及多个可解离地连接到该骨架的铂化合物。该发明还涉及二羰基脂类化合物，其中铂化合物可可解离地连接到二羰基化合物。该发明还涉及治疗癌症或转移的方法。该方法包括选择需要癌症或转移治疗的受试者，并向受试者施用该发明的任何纳米颗粒、化合物或组合物的有效量。
• Thermotropic liquid crystal polymer microcapsules, a method for preparing the same, and cosmetic compositions containing the same
  申请人：——

  公开号：US20030129247A1

  公开（公告）日：2003-07-10

  There are provided thermotropic liquid crystal polymer microcapsules which can show behavior of liquid crystal as it is within polymer phase due to phase separation between liquid crystal and polymer, so to be incorporated into cosmetic composition as an additive for visual effect, and in loading active ingredients within liquid crystal, can improve the stability of the active ingredients in cosmetic base; and a method for preparing the same; and cosmetic compositions containing the same.

  提供了热致液晶聚合物微胶囊，由于液晶与聚合物之间的相分离，这些微胶囊可以展现液晶在聚合物相中的行为，因此可以作为化妆品组合物中的添加剂用于视觉效果，并且在液晶中装载活性成分，可以提高这些活性成分在化妆品基料中的稳定性；以及制备这些微胶囊的方法；以及含有这些微胶囊的化妆品组合物。
• BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS
  申请人：Dietz Ulrich

  公开号：US20140099354A1

  公开（公告）日：2014-04-10

  The present invention relates to nitro-carboxylic acid (s)-containing phospholipids, to be used for coating of medical devices such as stents, catheter balloons, wound pads or surgical suture material and for bio-passivating compositions, such as rinses, waterproofing solutions, coating solutions, cryoprotection solutions, cold preservation media, lyoprotection solutions, contrast media solutions, preservation and reperfusion solutions containing these compounds as well as preparing solutions thereof and coating medical devices as well as their uses.

  本发明涉及一种含硝基羧酸（s）的磷脂，用于涂覆医疗器械，如支架、导管球囊、伤口垫或外科缝合材料，以及用于生物钝化组合物，如漱口液、防水溶液、涂层溶液、冷冻保护溶液、冷藏介质、冻干保护溶液、造影介质溶液、含有这些化合物的保存和再灌注溶液，以及制备这些溶液和涂覆医疗器械以及它们的用途。
• [EN] COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS<br/>[FR] COMPOSÉS ET COMPOSITIONS D'ADMINISTRATION INTRACELLULAIRE D'AGENTS THÉRAPEUTIQUES
  申请人：MODERNATX INC

  公开号：WO2018170306A1

  公开（公告）日：2018-09-20

  The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

  该披露涉及新型脂质和相关组合物。纳米粒子组合物包括一种新型脂质以及额外的脂质，如磷脂、结构脂质和PEG脂质。纳米粒子组合物还包括治疗和/或预防措施，如RNA，在将治疗和/或预防措施传递给哺乳动物细胞或器官方面非常有用，例如，调节多肽、蛋白质或基因表达。